Weihao Huang

weihao.huang@lw.com

+852.2912.2500

Capital Markets

Profile

Weihao Huang is an associate in the Hong Kong office of Latham & Watkins.

Weihao’s practices span an array of areas, including securities offerings, cross-border mergers and acquisitions, and other general corporate matters.

Prior to joining Latham, Weihao worked as an associate in Guangzhou office of a leading Chinese law firm, where he focused on mergers and acquisitions and other general corporate matters.

Experience

Weihao’s experience includes advising:

The underwriters on WeRide’s HK$2.4 billion initial public offering and dual primary listing on The Stock Exchange of Hong Kong. This is the first dual primary listed 18C Specialist Technology Company with a weighted voting right structure on the SEHK
The underwriters on the offering of 18,415,400 H shares by Asymchem Laboratories (Tianjin) Co., Ltd.
The underwriters on the offering of 9,714,000 H shares by AIM Vaccine Co., Ltd
The underwriters on the offering of 59,618,500 Shares by JF SmartInvest Holdings Ltd (formerly JF Wealth Holdings Ltd)
China Risun Group Limited on its top-up placing of shares